
Intellia Therapeutics (NTLA) Pullback Puts Its CRISPR Valuation Story Back In Focus
<a href="https://news.google.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?oc=5" target="_blank">Intellia Therapeutics (NTLA) Pullback Puts Its CRISPR Valuation Story Back In Focus</a>&nbsp;&nbsp;<font color="#6f6f6f">Simply Wall Street</font>

